2024 Q3 Form 10-Q Financial Statement

#000151597124000071 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $3.148M $4.343M $4.601M
YoY Change -32.86% -5.61% -10.18%
Cost Of Revenue $2.439M $3.443M $3.827M
YoY Change -28.78% -10.03% -18.23%
Gross Profit $709.4K $899.7K $774.1K
YoY Change -43.89% 16.23% 74.9%
Gross Profit Margin 22.53% 20.72% 16.82%
Selling, General & Admin $1.634M $1.764M $1.472M
YoY Change 73.0% 19.85% -13.56%
% of Gross Profit 230.39% 196.04% 190.12%
Research & Development $259.8K $387.8K $299.6K
YoY Change 40.19% 29.43% 160.34%
% of Gross Profit 36.63% 43.1% 38.71%
Depreciation & Amortization $2.450K $2.450K $3.090K
YoY Change -431.08% -20.71% 50.0%
% of Gross Profit 0.35% 0.27% 0.4%
Operating Expenses $1.897M $2.154M $1.774M
YoY Change 67.38% 21.4% -2.49%
Operating Profit -$1.187M -$1.254M -$1.000M
YoY Change -1005.84% 25.4% -27.36%
Interest Expense $407.00 $179.6K
YoY Change -99.81% 281.01%
% of Operating Profit
Other Income/Expense, Net -$1.694K -$4.763K -$222.4K
YoY Change -99.31% -97.86% 119.74%
Pretax Income -$1.189M -$1.259M -$1.223M
YoY Change 950.09% 2.98% -17.29%
Income Tax -$149.4K
% Of Pretax Income
Net Earnings -$1.189M -$1.110M -$1.223M
YoY Change 950.13% -9.24% -17.29%
Net Earnings / Revenue -37.76% -25.55% -26.57%
Basic Earnings Per Share -$0.03 -$0.03 -$0.03
Diluted Earnings Per Share -$0.03 -$0.03 -$0.03
COMMON SHARES
Basic Shares Outstanding 43.49M shares 43.35M shares 42.52M shares
Diluted Shares Outstanding 43.49M shares 43.41M shares 42.52M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.688M $3.681M $1.135M
YoY Change 103.33% 224.4% -53.32%
Cash & Equivalents $2.688M $3.681M $1.135M
Short-Term Investments
Other Short-Term Assets $1.302M $1.011M
YoY Change
Inventory $360.1K $554.9K $793.0K
Prepaid Expenses $133.2K $106.7K $9.098K
Receivables $1.860M $1.840M $1.438M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.344M $7.194M $3.375M
YoY Change 90.89% 113.14% -30.69%
LONG-TERM ASSETS
Property, Plant & Equipment $16.84K $19.29K $30.36K
YoY Change -38.27% -36.48% -28.92%
Goodwill
YoY Change
Intangibles $674.7K $705.9K $634.3K
YoY Change 6.38% 11.3% -24.97%
Long-Term Investments
YoY Change
Other Assets $74.54K $74.54K $74.54K
YoY Change 0.0% 0.0% -38.38%
Total Long-Term Assets $766.1K $799.7K $1.225M
YoY Change -35.52% -34.73% 20.23%
TOTAL ASSETS
Total Short-Term Assets $6.344M $7.194M $3.375M
Total Long-Term Assets $766.1K $799.7K $1.225M
Total Assets $7.110M $7.993M $4.600M
YoY Change 57.6% 73.76% -21.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.176M $3.139M $1.816M
YoY Change 60.04% 72.91% 46.47%
Accrued Expenses $125.4K $131.8K $123.0K
YoY Change 0.03% 7.17% 103.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $3.583M
YoY Change -100.0% -100.0% 20.07%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.301M $3.271M $5.522M
YoY Change -42.43% -40.76% 28.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $248.8K $274.5K $395.6K
YoY Change -31.52% -30.63% 138.98%
Total Long-Term Liabilities $248.8K $274.5K $395.6K
YoY Change -31.52% -30.63% 138.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.301M $3.271M $5.522M
Total Long-Term Liabilities $248.8K $274.5K $395.6K
Total Liabilities $3.550M $3.545M $5.917M
YoY Change -41.78% -40.08% 32.98%
SHAREHOLDERS EQUITY
Retained Earnings -$6.454M -$5.265M -$10.44M
YoY Change -38.81% -49.54% 51.93%
Common Stock $43.49K $43.47K $42.67K
YoY Change 1.47% 1.88% 2.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.560M $4.448M -$1.317M
YoY Change
Total Liabilities & Shareholders Equity $7.110M $7.993M $4.600M
YoY Change 57.6% 73.76% -21.88%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.189M -$1.110M -$1.223M
YoY Change 950.13% -9.24% -17.29%
Depreciation, Depletion And Amortization $2.450K $2.450K $3.090K
YoY Change -431.08% -20.71% 50.0%
Cash From Operating Activities -$992.9K -$203.7K -$884.0K
YoY Change -644.09% -76.95% -52.17%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 422.8K
YoY Change -100.0% -100.0% -85.04%
NET CHANGE
Cash From Operating Activities -992.9K -203.7K -884.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 0.000 422.8K
Net Change In Cash -992.9K -203.7K -461.3K
YoY Change -632.42% -55.83% -147.16%
FREE CASH FLOW
Cash From Operating Activities -$992.9K -$203.7K -$884.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
usd
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43472954 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43472954 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43145720 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43145720 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1259125 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1222720 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6973387 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2137417 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-149428 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1109697 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1222720 usd
us-gaap Net Income Loss
NetIncomeLoss
6973387 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137417 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43412602 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42520720 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43301670 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42539672 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43412602 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42520720 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43301670 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42539672 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3013405 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
446746 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41250 usd
us-gaap Net Income Loss
NetIncomeLoss
6973387 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4447978 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5334998 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
222677 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1109697 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4447978 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
282569 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
82500 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137417 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1316985 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-275485 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139970 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41250 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1222720 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1316985 usd
us-gaap Net Income Loss
NetIncomeLoss
6973387 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137417 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4899 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6176 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9247726 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-49579 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-89516 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
1448 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
14 usd
us-gaap Share Based Compensation
ShareBasedCompensation
446747 usd
us-gaap Share Based Compensation
ShareBasedCompensation
282569 usd
ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
41250 usd
ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-60901 usd
ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-67644 usd
ktel Change In Lease Liability
ChangeInLeaseLiability
-51983 usd
ktel Change In Lease Liability
ChangeInLeaseLiability
-58003 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
344885 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-71762 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-674911 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
266648 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-23018 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-51647 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10797 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
1000000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-570449 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
466629 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2990950 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1384861 usd
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
9558509 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9558509 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3704750 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
77250 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41250 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41250 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3663500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
464000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2904059 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-920861 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
777103 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2055634 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3681162 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1134773 usd
us-gaap Interest Paid Net
InterestPaidNet
54750 usd
us-gaap Interest Paid Net
InterestPaidNet
133500 usd
CY2014Q4 us-gaap Business Acquisition Description Of Acquired Entity
BusinessAcquisitionDescriptionOfAcquiredEntity
on November 1, 2014, it acquired most of the assets of Coast to Coast Cellular, Inc. (“Coast to Coast”), including inventories, property, plant and equipment and its customer list, all valued at approximately $950,000 net of liabilities in the approximate amount of $415,000; and on November 1, 2016, it acquired the assets of CS Agency LLC (“CS Agency”), consisting of contract rights related to the cellular industry, in consideration of assuming liabilities of CS Agency in the approximate amount of $300,000. With the completion of the KonaTel Nevada Merger, we succeeded to the current and intended business operations of KonaTel Nevada.
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
803480 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1109697 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1222720 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43412602 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42520720 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43412602 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42520720 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Net Income Loss
NetIncomeLoss
6973387 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137417 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43301670 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42539672 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43301670 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42539672 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zYLXnO5is6vb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of receivables, cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All cash and cash equivalents are held at high credit financial institutions. These deposits are generally insured under the FDIC’s deposit insurance coverage; however, from time to time, the deposit levels may exceed FDIC coverage levels.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91A_eus-gaap--TradeAccountsReceivableMember_zNTONWT6vf51" style="display: none">Trade Account Receivables</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_911_eus-gaap--CustomerConcentrationRiskMember_zH618ZxnVLm3" style="display: none">Customer Concentration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91B_eus-gaap--SalesRevenueNetMember_zSXLe5VDNloh" style="display: none">Sales Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a concentration of risk with respect to trade receivables from customers and cellular providers. As of June 30, 2024, the Company had a significant concentration of receivables (defined as customers whose receivable balances are greater than 10% of total receivables) due from two (2) customers in the amount of $<span id="xdx_90D_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zqEZO4dJa2Yl" title="Receivables, concentration">1,071,558</span> or <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zQsru44fYZn" title="Concentration risk">58.0</span>%, and $<span id="xdx_904_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_ze3jtap0Kpkc" title="Receivables, concentration">465,576</span> or <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_z4VIXgyuQgLl" title="Concentration risk">25.2</span>%. It should be noted that the largest customer is the State of California, and the second largest customer is the federal government, as administered by the Universal Service Administrative Company (“USAC”), under the authority of the FCC. As of December 31, 2023, the Company had a significant concentration of receivables from two (2) customers in the amounts of $<span id="xdx_900_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zUXLH2KfC9Xd" title="Receivables, concentration">1,024,308</span> or <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zBQnbPSCIaad" title="Concentration risk">68.5</span>%, and $<span id="xdx_90B_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zOoQdu6OEwK4" title="Receivables, concentration">285,536</span> or <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zWxdPZMREPPa" title="Concentration risk">19.0</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Net Income Loss
NetIncomeLoss
6973387 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137417 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5265304 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
554859 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1229770 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
442326 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
437427 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19285 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24184 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company had three (3) properties with lease terms in excess of one (1) year. Of these three (3) leases, one (1) lease expires in 2025, one (1) lease expires in 2026, and one (1) lease expires in 2030
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
406244 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
77940 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
129543 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
65967 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
54000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
54000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
90000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
471450 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
65206 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
406244 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
131787 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
274457 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P57M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0696 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
87594 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
86078 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
323468 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
323468 usd
CY2024Q2 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2023Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2024Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2024Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
323468 usd
CY2023Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
323468 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
382426 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
443328 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
705894 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1077579 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021Q4 us-gaap Liabilities Subject To Compromise Income Tax Contingencies
LiabilitiesSubjectToCompromiseIncomeTaxContingencies
7000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 number
us-gaap Revenues
Revenues
9979016 usd
us-gaap Gross Profit
GrossProfit
2027212 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4899 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2024Q2 us-gaap Revenues
Revenues
4343179 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
899707 usd
CY2024Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2449 usd
CY2024Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Revenues
Revenues
8633145 usd
us-gaap Gross Profit
GrossProfit
1775931 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6176 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2023Q2 us-gaap Revenues
Revenues
4601426 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
774052 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3088 usd
CY2023Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
446747 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
282569 usd
CY2024Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
222677 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
139970 usd
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
2101424 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M8D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
872463 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.78
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
400000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.43
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5700000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.78
ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y3M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
171339 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.59
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M21D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5944 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001515971-24-000071-index-headers.html Edgar Link pending
0001515971-24-000071-index.html Edgar Link pending
0001515971-24-000071.txt Edgar Link pending
0001515971-24-000071-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ktel-20240630.xsd Edgar Link pending
ktel-20240630_cal.xml Edgar Link unprocessable
ktel-20240630_def.xml Edgar Link unprocessable
ktel-20240630_lab.xml Edgar Link unprocessable
ktel10q063024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ktel-20240630_pre.xml Edgar Link unprocessable
ktel10q063024_htm.xml Edgar Link completed